Related news from
Fri, 14 Nov 2025 04:41:48 +0000	1 Healthcare Stock to Own for Decades and 2 We Avoid Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 11.6% has lagged the S&P 500’s 16.3% climb.
Wed, 12 Nov 2025 11:06:52 +0000	Cencora (COR): Assessing Valuation After Sustained Share Price Growth Shares of Cencora (COR) have been catching the attention of investors recently, with the stock showing marked movement over the past month and more than doubling in value across the past three years. Recent trading reflects a generally positive trajectory and has prompted closer inspection of what might be driving this performance. See our latest analysis for Cencora. Cencora’s share price momentum has steadily increased, notching a 14.8% gain over the past month and climbing 62.45%...
Wed, 12 Nov 2025 10:33:55 +0000	Why Cencora's (NYSE:COR) Earnings Are Better Than They Seem Investors signalled that they were pleased with Cencora, Inc.'s ( NYSE:COR ) most recent earnings report. Looking...
Wed, 12 Nov 2025 05:36:31 +0000	The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call Cencora’s third quarter saw a positive market response, as the company delivered revenue and non-GAAP earnings that exceeded Wall Street expectations. Management pointed to strong growth in its U.S. Healthcare Solutions segment and the contribution of specialty pharmaceuticals as key drivers. CEO Robert Mauch emphasized that investments in areas like specialty distribution and recent acquisitions, such as Retina Consultants of America, enhanced the company’s value to both pharmaceutical manufact
Tue, 11 Nov 2025 09:51:02 +0000	Cencora Stock: Is Wall Street Bullish or Bearish? Pharma distributor Cencora has continued to outpace the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.
Thu, 06 Nov 2025 21:45:40 +0000	Cencora makes $1 billion investment in pharma supply chains Cencora is betting on the future of pharmaceutical logistics, announcing a $1 billion investment through 2030 to expand and modernize its U.S. distribution infrastructure. This move is not just network growth, but a shift aimed at supporting the rising demand of prescription medications and strengthening the reliability of the supply chain that delivers them. The […] The post Cencora makes $1 billion investment in pharma supply chains appeared first on FreightWaves.
Thu, 06 Nov 2025 11:21:22 +0000	Cencora to invest $1bn in US pharma distribution network The second national distribution centre, which is in Harrison, Ohio, will be operational by spring 2027.
Thu, 06 Nov 2025 08:16:20 +0000	Cencora (COR): $713 Million One-Off Loss Challenges Bull Case on Margin Recovery Cencora (COR) posted a net profit margin of 0.6%, a notch below last year’s 0.7%, while earnings rose 2.2% in the latest period, a significant slowdown from its 48.8% average annual growth rate over the past five years. Looking ahead, analysts expect earnings to increase by 11.04% per year, trailing the broader US market’s 16%, with the top line forecast to grow 6.7% versus the market’s 10.5%. However, the results were overshadowed by a one-off loss of $713.2 million in the trailing 12 months...
Thu, 06 Nov 2025 05:34:31 +0000	COR Q3 Deep Dive: Specialty Expansion and Portfolio Restructuring Drive Strategic Focus Healthcare distributor Cencora (NYSE:COR) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.9% year on year to $83.73 billion. Its non-GAAP profit of $3.84 per share was 1.4% above analysts’ consensus estimates.
Wed, 05 Nov 2025 22:23:12 +0000	McKesson raises annual profit forecast on robust demand for specialty drugs (Reuters) -Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.
Wed, 05 Nov 2025 21:00:34 +0000	Cencora Inc (COR) Q4 2025 Earnings Call Highlights: Strategic Investments Propel Growth Amid ... Cencora Inc (COR) reports robust growth in adjusted income and EPS, while navigating goodwill impairments and strategic realignments.
Wed, 05 Nov 2025 16:54:00 +0000	Rigetti Computing to Post Q3 Earnings: What's in Store for the Stock? RGTI's Q3 results are likely to gain from U.S. funding clarity, new contracts and gains from its next-gen quantum system.
Wed, 05 Nov 2025 15:56:00 +0000	COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves Cencora's Q4 results top estimates with 15% EPS growth and stronger margins, as GLP-1 demand and the RCA acquisition fuel solid segment gains.
Wed, 05 Nov 2025 15:38:05 +0000	Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast By Padmanabhan Ananthan (Reuters) -Cencora will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after forecasting adjusted profit for next year
Wed, 05 Nov 2025 15:06:14 +0000	Cencora (COR) Q4 2025 Earnings Call Transcript Bennett S. Murphy: Thank you. Good morning, good afternoon, and thank you for joining us for this conference call to discuss Cencora, Inc.'s fiscal 2025 fourth quarter and full year results. Joining me today are Robert P. Mauch, President and CEO, and James F. Cleary, Executive Vice President and CFO.
Wed, 05 Nov 2025 14:30:10 +0000	Cencora (COR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Wed, 05 Nov 2025 12:40:01 +0000	Cencora (COR) Q4 Earnings and Revenues Surpass Estimates Cencora (COR) delivered earnings and revenue surprises of +1.32% and +0.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Wed, 05 Nov 2025 12:00:00 +0000	Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain The company will open two new distribution centers and expand a third as demand surges for GLP-1s and other refrigerated medications.
Wed, 05 Nov 2025 12:00:00 +0000	Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network CONSHOHOCKEN, Pa., November 05, 2025--Cencora, a global pharmaceutical solutions company, today announced plans to invest $1 billion through 2030 to bolster and expand its pharmaceutical distribution network in the United States. The investments — headlined by the opening of its second national distribution center in Ohio and an expanded presence in Alabama and California — will increase Cencora’s capacity, improve efficiency and enhance the resilience of its national distribution network, stren
Wed, 05 Nov 2025 11:44:39 +0000	Cencora’s (NYSE:COR) Q3 Sales Top Estimates Healthcare distributor Cencora (NYSE:COR) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.9% year on year to $83.73 billion. Its non-GAAP profit of $3.84 per share was 1.4% above analysts’ consensus estimates.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!